In this episode, we meet Julia Bernstein, General Manager of Platform at Thirty Madison. Thirty Madison provides virtual specialty care through a mix of direct-to-consumer and reimbursable models that includes doctor consults, treatment delivery, and ongoing care. They’re on a mission to make specialized care and treatment accessible to everyone. First with Keeps, a men’s hair loss solution, then with Cove, which focuses on migraine, followed by Evens which treats GI symptoms, and most recently, Picnic for allergies, Thirty Madison is continuously expanding their offerings to find answers to chronic conditions. With a patient-first approach that provides care and support from diagnosis to treatment and tracking, they work to improve how millions of people manage their chronic conditions. Thirty Madison has raised over $70 million from Polaris Partners, Johnson and Johnson Innovation, Northzone, and Maveron, to name a few.

Prior to Thirty Madison, Julia was COO of Tempest and held strategy, operations, and sales leadership roles at Beacon Health Options, Institute on Aging, and Ginger. Julia spent her early career serving healthcare companies on new business innovation at McKinsey and Company. Julia is also a Board Member of PharmaCCX and an advisor to Care + Wear. She holds an MBA from Stanford University Graduate School of Business and a bachelor’s from Dartmouth College.

In this episode, Julia and I chat about:

• The trends and changes in healthcare consumer behavior that have led to the rise of direct-to-consumer (DTC) healthcare businesses
• How Thirty Madison delivers personalized specialty care for patients with chronic conditions at half the price of local pharmacies
• Approach to partnerships with payers and pharma who share Thirty Madison’s commitment to access for all
• The impact of the COVID-19 pandemic and what’s in store for Thirty Madison in 2021